Resumen
BCAS3 microtubule-associated cell migration factor (BCAS3) is a large, highly conserved cytoskeletal protein previously proposed to be critical in angiogenesis and implicated in human embryogenesis and tumorigenesis. Here, we established BCAS3 loss-of-function variants as causative for a neurodevelopmental disorder. We report 15 individuals from eight unrelated families with germline bi-allelic loss-of-function variants in BCAS3. All probands share a global developmental delay accompanied by pyramidal tract involvement, microcephaly, short stature, strabismus, dysmorphic facial features, and seizures. The human phenotype is less severe compared with the Bcas3 knockout mouse model and cannot be explained by angiogenic defects alone. Consistent with being loss-of-function alleles, we observed absence of BCAS3 in probands’ primary fibroblasts. By comparing the transcriptomic and proteomic data based on probands’ fibroblasts with those of the knockout mouse model, we identified similar dysregulated pathways resulting from over-representation analysis, while the dysregulation of some proposed key interactors could not be confirmed. Together with the results from a tissue-specific Drosophila loss-of-function model, we demonstrate a vital role for BCAS3 in neural tissue development.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 1069-1082 |
Número de páginas | 14 |
Publicación | American Journal of Human Genetics |
Volumen | 108 |
N.º | 6 |
DOI | |
Estado | Published - jun. 3 2021 |
Nota bibliográfica
Funding Information:We are grateful to the affected individuals and their families whose cooperation made this study possible. The study has been supported by the Deutsche Forschungsgemeinschaft (DFG, grant SCHO754/2-1 to L.S.) and funding of the NGS Competence Center Tübingen ( INST 37/1049-1 ), the Solve-RD project (grant 779257 to H. Hengel, A.J., and L.S.), the US National Human Genome Research Institute ( NHGRI ) and National Heart Lung and Blood Institute ( NHLBI ) to the Baylor-Hopkins Center for Mendelian Genomics (BHCMG, UM1 HG006542 , J.R.L.), the US National Institute of Neurological Disorders and Stroke ( NINDS ) ( R35NS105078 to J.R.L.), and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme and made possible through access to the data and findings generated by the 100,000 Genomes Project (managed by Genomics England Limited and funded by the NIHR and NHS England), by the Care4Rare Canada Consortium funded by Genome Canada and the Ontario Genomics Institute ( OGI-147 ), the Canadian Institutes of Health Research, Ontario Research Fund, Genome Alberta, Genome British Columbia, Genome Quebec, and Children’s Hospital of Eastern Ontario Foundation, and by the NIH R01 ( 2R01NS058721-07A1 ). H. Hengel was supported by the fortüne program of the University of Tübingen (grant # 2554-0-0 ). H. Hengel and L.S. are members of the European Reference Network for Rare Neurological Diseases (project ID 739510 ). D.P. was supported by a Clinical Research Training Scholarship in Neuromuscular Disease partnered by the American Brain Foundation and Muscle Study Group and International Rett Syndrome Foundation (IRSF grant # 3701 - 1 ). T.B.H. was supported by the DFG (project number 418081722 ). The families were collected as part of the SYNaPS Study Group collaboration funded by the Wellcome Trust and strategic award (Synaptopathies) funding ( WT093205 MA and WT104033AIA ).
Publisher Copyright:
© 2021 American Society of Human Genetics
ASJC Scopus Subject Areas
- Genetics
- Genetics(clinical)
PubMed: MeSH publication types
- Case Reports
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't